drugset / Trial / NCT00511719
Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the kinetics and biodynamics of inhaled Technosphere Insulin with those of subcutaneous (SC) regular human insulin.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-04
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | 24 iu | Subcutaneous |
| Comparator | Insulin | Protein / enzyme biologic | 48 iu | Inhaled |